Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in the News section are encouraged to email their news releases to BioNJ.
May 15
Former Pro Football Coach Bill Cowher Teams Up With Leading Advocacy Groups to Launch Melanoma Exposed™, an Educational Campaign to Raise Awareness of the Most Deadly Form of Skin Cancer
Celldex Therapeutics Added to Nasdaq Biotechnology Index
Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical Sales and Marketing
Derma Sciences Reports First Quarter 2012 Financial Results
Advaxis Retires $4.5 Million in Debt, Adds $1,240,000 in New Financing
Senesco Technologies Reports Fiscal 2012 Third Quarter Results
May 14
Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
Cyclacel Reports First Quarter 2012 Financial Results
Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership
May 11
Arno Therapeutics Announces Orphan-Drug Designation for AR-42 in Europe
Derma Sciences to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
Paragon Sponsors CBI Conference on Electronic Trial Master File Implementation
May 10
Onconova Advances Oral Rigosertib to Phase II Clinical Trial in Myelodysplastic Syndromes
Antares Pharma to Present at the 15th Annual Bank of America Merrill Lynch Health Care Conference
Amicus Therapeutics Announces First Quarter 2012 Financial Results
Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference
May 8
Cyclacel Pharmaceuticals to Announce Release of First Quarter 2012 Financial Results
Immunomedics Announces Third Quarter Fiscal 2012 Results and Clinical Program Developments
Antares Pharma Reports First Quarter 2012 Financial and Operating Results
Merck to Present at Deutsche Bank 37th Annual Health Care Conference
The Medicines Company to Participate in Bank of America Merrill Lynch 2012 Healthcare Conference
May 7
Celgene Corporation Announces Appointment of Thomas M. Moriarty as General Counsel
Global Life Science hiring increases nearly 4% during Q1 2012
Unigene Announces First Quarter 2012 Financial Results
May 4
Columbia Laboratories Reports First Quarter 2012 Financial Results
Celgene Corporation to Present at Two Upcoming Investor Conferences
May 3
Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 First Quarter Results
Celldex Reports First Quarter 2012 Financial Results
NPS Pharmaceuticals Reports First Quarter 2012 Financial Results
Enzon Reports First Quarter 2012 Results
Kevin C. O’Boyle Joins Durata Therapeutics’ Board of Directors
Lexicon Receives Funding for Phase 2 Clinical Trial of Lx4211 in Type 1 Diabetes
May 1
Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer
Aegerion Pharmaceuticals Announces First Quarter 2012 Financial Results
Antares Pharma to Host First Quarter 2012 Earnings Call
Combination of Lenalidomide and SNS01-T Effective in Cancer Model
April 30
Aegerion Pharmaceuticals Announces FDA Acceptance of New Drug Application for Review
Bristol-Myers Squibb to Present at Deutsche Bank Health Care Conference
Strength of Aptalis Pharmaceutical Technologies Patents Confirmed by AMRIX® Verdict
April 27
NPS Pharmaceuticals to Report First Quarter 2012 Financial Results
Novo Nordisk Plans 15 Percent Expansion of U.S. Work Force in 2012
April 26
Announcement of the 1st Quarter Report 2012
NPS Pharmaceuticals Among 100 Best Places to Work in New Jersey
Merck Wins U.S. ZETIA® (ezetimibe)/ VYTORIN®(ezetimibe/simvastatin) Patent Infringement Lawsuit
Merck Announces First-Quarter 2012 Financial Results
Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva and Pfizer
Watson and Antares Announce the Introduction of Gelnique 3%™ for the Treatment of Overactive Bladder
Celgene Reports First Quarter 2012 Operating and Financial Results
Senator Bob Menendez Honored as BIO Legislator of the Year
Advaxis to Speak at 2012 World Immunotherapy Online Symposium
Recipients of 2012 SAFE-BioPharma “Digi” Awards Named
Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
AstraZeneca and The Medicines Company Announce Global Collaboration in Acute Ischemic Heart Disease
Lexicon to Provide First Quarter 2012 Financial Results
The Medicines Company Reports First Quarter 2012 Financial Results
Columbia Laboratories to Discuss First Quarter 2012 Financial Results on May 4 Conference Call
Photocure Launches New Corporate Website
April 18
Merck Wins Another FOSAMAX® (alendronate sodium) State Court Trial
April 17
Cyclacel Pharmaceuticals Announces Grant of New U.S. Patent Covering Sapacitabine
“What Every Mama Needs To Know About Cord Blood Banking”
Celgene Corporation to Announce First Quarter 2012 Results on April 26, 2012
Decision Resources Group Acquires Pinsonault
Bristol-Myers Squibb Ranks First on 2012 Best Corporate Citizens List
Amicus Therapeutics Names William D. Baird, III Chief Financial Officer